AstraZeneca CEO on Impact of Midterms on Drug Market

The transcript discusses the potential impacts of US market trends and legislative changes on pharmaceutical pricing, highlighting the role of rebates and the need for transparency. It explores global pricing strategies, emphasizing the US's support for innovation and R&D. The growth in China is analyzed, noting the country's evolving market dynamics and government policies. Finally, the transcript addresses business preparations for Brexit, focusing on investments in the UK and recruitment challenges.

How has the growth of the pharmaceutical market in China been characterized in recent years?

Evaluate responses using AI:

OFF

What changes have occurred in the approval process for new drugs in China?

Evaluate responses using AI:

OFF

What challenges do older pharmaceutical products face in terms of pricing?

Evaluate responses using AI:

OFF